+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Muscle-invasive Bladder Cancer Therapeutics Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

  • PDF Icon

    Report

  • 321 Pages
  • January 2024
  • Region: Global
  • Fairfield Market Research
  • ID: 5934288
Description Jump to:
The global muscle-invasive bladder cancer therapeutics market reached a value of US$1.2 billion in 2024. The market is predicted to surge ahead at a CAGR of 15.8% and end up at US$4.0 billion by 2031.

Factors Driving the Muscle-invasive Bladder Cancer Therapeutics Market

The global muscle-invasive bladder cancer (MIBC) therapeutics market is poised for significant growth, primarily fueled by the increasing incidence of bladder cancer worldwide. According to the World Health Organization (WHO), over 0.6 million people are diagnosed with bladder cancer annually, with more than 200,000 succumbing to the disease. As the incidence of bladder cancer continues to rise, the demand for effective treatment options for MIBC is expected to surge.

The availability of new and innovative treatments, including immunotherapy, targeted therapy, and chemotherapy, has revolutionized MIBC treatment. Recent advances in these therapies, such as pembrolizumab and atezolizumab, have shown promising results in clinical trials, offering new hope to MIBC patients.

Factors Driving Adoption of MIBC Therapies

The development of innovative therapies targeting specific biomarkers or pathways involved in MIBC is driving market growth. Therapies targeting PD-L1, FGFR3, or HER2/neu have shown significant promise in clinical trials, providing new avenues for MIBC treatment.

Additionally, the adoption of personalized medicine, where treatments are tailored to the genetic makeup of each patient, is gaining traction. Advanced genomic sequencing technologies enable the identification of specific genetic mutations driving MIBC tumors, paving the way for targeted therapies.

Challenges Hindering Market Growth

Despite the promising advancements, challenges such as high treatment costs and unfavorable side effects of MIBC therapeutics persist. The high cost of treatment can be a significant barrier for patients, particularly in developing economies with limited access to healthcare services. Additionally, limited treatment options and lack of awareness among patients and healthcare providers pose challenges to market expansion.

Country-wise Insights

  • United States: With a dominant market share, the U.S. market is driven by the demand for minimally invasive procedures and ongoing clinical trials for novel medications.
  • China: Favorable government policies and increasing clinical trials are driving market growth in China, fueled by the country's aging population and rising healthcare costs.
  • Germany: Growing public awareness and research efforts contribute to market expansion in Germany, with the country leading the European region in market share.

Category-wise Insights

  • Cancer Grade Dominating Market Share: Low-grade bladder cancer leads the market, emphasizing the need for prevention and early treatment to avoid progression to high-grade cancer.
  • Extensively Used Drug Type: Chemotherapy drugs are extensively used in MIBC treatment, offering improved patient outcomes and driving market growth.

Competition Analysis

The market is highly competitive, with leading players actively participating in research and development and increasing clinical trials to develop novel drugs. Collaboration among industry players is expected to further drive market growth and improve patient outcomes.
  • Pfizer Inc.
  • Merck KGaA
  • AstraZeneca PLC
  • Roche Holding AG (Genentech)
  • Astella
  • J&J (Janssen Biotech)
  • Cipla Inc.
  • Amneal Pharma
  • Bristol Myers Squibb Co.
  • Dr. Reddy’s Laboratories, Inc.
  • Gilead Sciences Inc.
  • Endo Pharma
  • UroGen Pharma, Inc.
  • Teva Pharmaceuticals (Actavis)
  • Hikma Pharmaceuticals
  • Incyte

Muscle-invasive Bladder Cancer Therapeutics Industry Segments

Cancer Grade:

  • Low-grade Bladder Cancer
  • High-grade Bladder Cancer

Drug Type:

  • Immunotherapy
  • Bacillus Calmette-Guerin
  • Avelumab
  • Nivolumab
  • Pembrolizumab
  • Others
  • Chemotherapy
  • Mitomycin C
  • Docetaxel
  • Paclitaxel
  • Cisplatin
  • Others
  • Targeted Therapy
  • Erdafitinib
  • Enfortumab Vedotin-ejfv
  • Sacituzumab Govitecan
  • Others

Distribution Channel:

  • Hospitals Pharmacies
  • Retail Pharmacies
  • Specialty Pharmacies
  • Online Pharmacies

Region:

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East & Africa


This product will be delivered within 1-3 business days.

Table of Contents

1. Executive Summary
1.1. Global Failure Analysis Equipment Market Snapshot
1.2. Future Projections
1.3. Key Market Trends
1.4. Regional Snapshot, by Value and Volume, 2023
1.5. Analyst Recommendations
2. Market Overview
2.1. Market Definitions and Segmentations
2.2. Market Dynamics
2.2.1. Drivers
2.2.2. Restraints
2.2.3. Market Opportunities
2.3. Value Chain Analysis
2.4. Porter’s Five Forces Analysis
2.5. COVID-19 Impact Analysis
2.5.1. Supply
2.5.2. Demand
2.6. Impact of Ukraine-Russia Conflict
2.7. Economic Overview
2.7.1. World Economic Projections
2.8. PESTLE Analysis
3. Price Analysis, 2018 - 2023
3.1. Global Average Price Analysis, by Equipment Type/ Technology, US$ Per Unit, 2018 - 2023
3.2. Prominent Factor Affecting Breast Tissue Markers Prices
3.3. Global Average Price Analysis, by Region, US$ Per Unit
4. Global Failure Analysis Equipment Market Outlook, 2018 - 2031
4.1. Global Failure Analysis Equipment Market Outlook, by Equipment Type, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
4.1.1. Key Highlights
4.1.1.1. Scanning Electron Microscope
4.1.1.2. Transmission Electron Microscope
4.1.1.3. Focused Ion Beam System
4.1.1.4. Dual-beam Systems
4.2. Global Failure Analysis Equipment Market Outlook, by Technology, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
4.2.1. Key Highlights
4.2.1.1. Broad Ion Milling (BIM) Technology
4.2.1.2. Chemical Mechanical Planarization (CMP) Technology
4.2.1.3. Energy Dispersive X-ray Spectroscopy (EDX) Technology
4.2.1.4. Focused Ion Beam (FIB) Technology
4.2.1.5. Reactive Ion Etching (RIE) Technology
4.2.1.6. Secondary Ion Mass Spectroscopy (SIMS) Technology
4.3. Global Failure Analysis Equipment Market Outlook, by Application, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
4.3.1. Key Highlights
4.3.1.1. Industrial Science
4.3.1.2. Material Science
4.3.1.3. Bioscience
4.3.1.4. Electronics
4.4. Global Failure Analysis Equipment Market Outlook, by Region, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
4.4.1. Key Highlights
4.4.1.1. North America
4.4.1.2. Europe
4.4.1.3. Asia Pacific
4.4.1.4. Latin America
4.4.1.5. Middle East & Africa
5. North America Failure Analysis Equipment Market Outlook, 2018 - 2031
5.1. North America Failure Analysis Equipment Market Outlook, by Equipment Type, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
5.1.1. Key Highlights
5.1.1.1. Scanning Electron Microscope
5.1.1.2. Transmission Electron Microscope
5.1.1.3. Focused Ion Beam System
5.1.1.4. Dual-beam Systems
5.2. North America Failure Analysis Equipment Market Outlook, by Technology, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
5.2.1. Key Highlights
5.2.1.1. Broad Ion Milling (BIM) Technology
5.2.1.2. Chemical Mechanical Planarization (CMP) Technology
5.2.1.3. Energy Dispersive X-ray Spectroscopy (EDX) Technology
5.2.1.4. Focused Ion Beam (FIB) Technology
5.2.1.5. Reactive Ion Etching (RIE) Technology
5.2.1.6. Secondary Ion Mass Spectroscopy (SIMS) Technology
5.3. North America Failure Analysis Equipment Market Outlook, by Application, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
5.3.1. Key Highlights
5.3.1.1. Industrial Science
5.3.1.2. Material Science
5.3.1.3. Bioscience
5.3.1.4. Electronics
5.4. North America Failure Analysis Equipment Market Outlook, by Country, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
5.4.1. Key Highlights
5.4.1.1. U.S. Failure Analysis Equipment Market by Equipment Type, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
5.4.1.2. U.S. Failure Analysis Equipment Market by Technology, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
5.4.1.3. U.S. Failure Analysis Equipment Market by Application, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
5.4.1.4. Canada Failure Analysis Equipment Market by Equipment Type, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
5.4.1.5. Canada Failure Analysis Equipment Market by Technology, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
5.4.1.6. Canada Failure Analysis Equipment Market by Application, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
5.4.2. BPS Analysis/Market Attractiveness Analysis
6. Europe Failure Analysis Equipment Market Outlook, 2018 - 2031
6.1. Europe Failure Analysis Equipment Market Outlook, by Equipment Type, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
6.1.1. Key Highlights
6.1.1.1. Scanning Electron Microscope
6.1.1.2. Transmission Electron Microscope
6.1.1.3. Focused Ion Beam System
6.1.1.4. Dual-beam Systems
6.2. Europe Failure Analysis Equipment Market Outlook, by Technology, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
6.2.1. Key Highlights
6.2.1.1. Broad Ion Milling (BIM) Technology
6.2.1.2. Chemical Mechanical Planarization (CMP) Technology
6.2.1.3. Energy Dispersive X-ray Spectroscopy (EDX) Technology
6.2.1.4. Focused Ion Beam (FIB) Technology
6.2.1.5. Reactive Ion Etching (RIE) Technology
6.2.1.6. Secondary Ion Mass Spectroscopy (SIMS) Technology
6.3. Europe Failure Analysis Equipment Market Outlook, by Application, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
6.3.1. Key Highlights
6.3.1.1. Industrial Science
6.3.1.2. Material Science
6.3.1.3. Bioscience
6.3.1.4. Electronics
6.4. Europe Failure Analysis Equipment Market Outlook, by Country, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
6.4.1. Key Highlights
6.4.1.1. Germany Failure Analysis Equipment Market by Equipment Type, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
6.4.1.2. Germany Failure Analysis Equipment Market by Technology, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
6.4.1.3. Germany Failure Analysis Equipment Market by Application, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
6.4.1.4. U.K. Failure Analysis Equipment Market by Equipment Type, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
6.4.1.5. U.K. Failure Analysis Equipment Market by Technology, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
6.4.1.6. U.K. Failure Analysis Equipment Market by Application, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
6.4.1.7. France Failure Analysis Equipment Market by Equipment Type, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
6.4.1.8. France Failure Analysis Equipment Market by Technology, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
6.4.1.9. France Failure Analysis Equipment Market by Application, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
6.4.1.10. Italy Failure Analysis Equipment Market by Equipment Type, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
6.4.1.11. Italy Failure Analysis Equipment Market by Technology, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
6.4.1.12. Italy Failure Analysis Equipment Market by Application, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
6.4.1.13. Turkey Failure Analysis Equipment Market by Equipment Type, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
6.4.1.14. Turkey Failure Analysis Equipment Market by Technology, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
6.4.1.15. Turkey Failure Analysis Equipment Market by Application, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
6.4.1.16. Russia Failure Analysis Equipment Market by Equipment Type, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
6.4.1.17. Russia Failure Analysis Equipment Market by Technology, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
6.4.1.18. Russia Failure Analysis Equipment Market by Application, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
6.4.1.19. Rest of Europe Failure Analysis Equipment Market by Equipment Type, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
6.4.1.20. Rest of Europe Failure Analysis Equipment Market by Technology, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
6.4.1.21. Rest of Europe Failure Analysis Equipment Market by Application, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
6.4.2. BPS Analysis/Market Attractiveness Analysis
7. Asia Pacific Failure Analysis Equipment Market Outlook, 2018 - 2031
7.1. Asia Pacific Failure Analysis Equipment Market Outlook, by Equipment Type, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
7.1.1. Key Highlights
7.1.1.1. Scanning Electron Microscope
7.1.1.2. Transmission Electron Microscope
7.1.1.3. Focused Ion Beam System
7.1.1.4. Dual-beam Systems
7.2. Asia Pacific Failure Analysis Equipment Market Outlook, by Technology, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
7.2.1. Key Highlights
7.2.1.1. Broad Ion Milling (BIM) Technology
7.2.1.2. Chemical Mechanical Planarization (CMP) Technology
7.2.1.3. Energy Dispersive X-ray Spectroscopy (EDX) Technology
7.2.1.4. Focused Ion Beam (FIB) Technology
7.2.1.5. Reactive Ion Etching (RIE) Technology
7.2.1.6. Secondary Ion Mass Spectroscopy (SIMS) Technology
7.3. Asia Pacific Failure Analysis Equipment Market Outlook, by Application, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
7.3.1. Key Highlights
7.3.1.1. Industrial Science
7.3.1.2. Material Science
7.3.1.3. Bioscience
7.3.1.4. Electronics
7.4. Asia Pacific Failure Analysis Equipment Market Outlook, by Country, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
7.4.1. Key Highlights
7.4.1.1. China Failure Analysis Equipment Market by Equipment Type, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
7.4.1.2. China Failure Analysis Equipment Market by Technology, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
7.4.1.3. China Failure Analysis Equipment Market by Application, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
7.4.1.4. Japan Failure Analysis Equipment Market by Equipment Type, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
7.4.1.5. Japan Failure Analysis Equipment Market by Technology, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
7.4.1.6. Japan Failure Analysis Equipment Market by Application, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
7.4.1.7. South Korea Failure Analysis Equipment Market by Equipment Type, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
7.4.1.8. South Korea Failure Analysis Equipment Market by Technology, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
7.4.1.9. South Korea Failure Analysis Equipment Market by Application, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
7.4.1.10. India Failure Analysis Equipment Market by Equipment Type, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
7.4.1.11. India Failure Analysis Equipment Market by Technology, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
7.4.1.12. India Failure Analysis Equipment Market by Application, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
7.4.1.13. Southeast Asia Failure Analysis Equipment Market by Equipment Type, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
7.4.1.14. Southeast Asia Failure Analysis Equipment Market by Technology, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
7.4.1.15. Southeast Asia Failure Analysis Equipment Market by Application, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
7.4.1.16. Rest of Asia Pacific Failure Analysis Equipment Market by Equipment Type, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
7.4.1.17. Rest of Asia Pacific Failure Analysis Equipment Market by Technology, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
7.4.1.18. Rest of Asia Pacific Failure Analysis Equipment Market by Application, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
7.4.2. BPS Analysis/Market Attractiveness Analysis
8. Latin America Failure Analysis Equipment Market Outlook, 2018 - 2031
8.1. Latin America Failure Analysis Equipment Market Outlook, by Equipment Type, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
8.1.1. Key Highlights
8.1.1.1. Scanning Electron Microscope
8.1.1.2. Transmission Electron Microscope
8.1.1.3. Focused Ion Beam System
8.1.1.4. Dual-beam Systems
8.2. Latin America Failure Analysis Equipment Market Outlook, by Technology, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
8.2.1. Key Highlights
8.2.1.1. Broad Ion Milling (BIM) Technology
8.2.1.2. Chemical Mechanical Planarization (CMP) Technology
8.2.1.3. Energy Dispersive X-ray Spectroscopy (EDX) Technology
8.2.1.4. Focused Ion Beam (FIB) Technology
8.2.1.5. Reactive Ion Etching (RIE) Technology
8.2.1.6. Secondary Ion Mass Spectroscopy (SIMS) Technology
8.3. Latin America Failure Analysis Equipment Market Outlook, by Application, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
8.3.1. Key Highlights
8.3.1.1. Industrial Science
8.3.1.2. Material Science
8.3.1.3. Bioscience
8.3.1.4. Electronics
8.4. Latin America Failure Analysis Equipment Market Outlook, by Country, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
8.4.1. Key Highlights
8.4.1.1. Brazil Failure Analysis Equipment Market by Equipment Type, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
8.4.1.2. Brazil Failure Analysis Equipment Market by Technology, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
8.4.1.3. Brazil Failure Analysis Equipment Market by Application, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
8.4.1.4. Mexico Failure Analysis Equipment Market by Equipment Type, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
8.4.1.5. Mexico Failure Analysis Equipment Market by Technology, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
8.4.1.6. Mexico Failure Analysis Equipment Market by Application, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
8.4.1.7. Argentina Failure Analysis Equipment Market by Equipment Type, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
8.4.1.8. Argentina Failure Analysis Equipment Market by Technology, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
8.4.1.9. Argentina Failure Analysis Equipment Market by Application, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
8.4.1.10. Rest of Latin America Failure Analysis Equipment Market by Equipment Type, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
8.4.1.11. Rest of Latin America Failure Analysis Equipment Market by Technology, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
8.4.1.12. Rest of Latin America Failure Analysis Equipment Market by Application, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
8.4.2. BPS Analysis/Market Attractiveness Analysis
9. Middle East & Africa Failure Analysis Equipment Market Outlook, 2018 - 2031
9.1. Middle East & Africa Failure Analysis Equipment Market Outlook, by Equipment Type, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
9.1.1. Key Highlights
9.1.1.1. Scanning Electron Microscope
9.1.1.2. Transmission Electron Microscope
9.1.1.3. Focused Ion Beam System
9.1.1.4. Dual-beam Systems
9.2. Middle East & Africa Failure Analysis Equipment Market Outlook, by Technology, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
9.2.1. Key Highlights
9.2.1.1. Broad Ion Milling (BIM) Technology
9.2.1.2. Chemical Mechanical Planarization (CMP) Technology
9.2.1.3. Energy Dispersive X-ray Spectroscopy (EDX) Technology
9.2.1.4. Focused Ion Beam (FIB) Technology
9.2.1.5. Reactive Ion Etching (RIE) Technology
9.2.1.6. Secondary Ion Mass Spectroscopy (SIMS) Technology
9.3. Middle East & Africa Failure Analysis Equipment Market Outlook, by Application, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
9.3.1. Key Highlights
9.3.1.1. Industrial Science
9.3.1.2. Material Science
9.3.1.3. Bioscience
9.3.1.4. Electronics
9.4. Middle East & Africa Failure Analysis Equipment Market Outlook, by Country, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
9.4.1. Key Highlights
9.4.1.1. GCC Failure Analysis Equipment Market by Equipment Type, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
9.4.1.2. GCC Failure Analysis Equipment Market by Technology, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
9.4.1.3. GCC Failure Analysis Equipment Market by Application, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
9.4.1.4. South Africa Failure Analysis Equipment Market by Equipment Type, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
9.4.1.5. South Africa Failure Analysis Equipment Market by Technology, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
9.4.1.6. South Africa Failure Analysis Equipment Market by Application, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
9.4.1.7. Egypt Failure Analysis Equipment Market by Equipment Type, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
9.4.1.8. Egypt Failure Analysis Equipment Market by Technology, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
9.4.1.9. Egypt Failure Analysis Equipment Market by Application, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
9.4.1.10. Nigeria Failure Analysis Equipment Market by Equipment Type, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
9.4.1.11. Nigeria Failure Analysis Equipment Market by Technology, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
9.4.1.12. Nigeria Failure Analysis Equipment Market by Application, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
9.4.1.13. Rest of Middle East & Africa Failure Analysis Equipment Market by Equipment Type, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
9.4.1.14. Rest of Middle East & Africa Failure Analysis Equipment Market by Technology, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
9.4.1.15. Rest of Middle East & Africa Failure Analysis Equipment Market by Application, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
9.4.2. BPS Analysis/Market Attractiveness Analysis
10. Competitive Landscape
10.1. Equipment Type vs Technology Heatmap
10.2. Company Market Share Analysis, 2023
10.3. Competitive Dashboard
10.4. Company Profiles
10.4.1. A&D Company
10.4.1.1. Company Overview
10.4.1.2. Product Portfolio
10.4.1.3. Financial Overview
10.4.1.4. Business Strategies and Development
10.4.2. Thermo Fisher Scientific (FEI Company)
10.4.2.1. Company Overview
10.4.2.2. Product Portfolio
10.4.2.3. Financial Overview
10.4.2.4. Business Strategies and Development
10.4.3. Hitachi High-Technologies Corporation
10.4.3.1. Company Overview
10.4.3.2. Product Portfolio
10.4.3.3. Financial Overview
10.4.3.4. Business Strategies and Development
10.4.4. Intertek Group plc
10.4.4.1. Company Overview
10.4.4.2. Product Portfolio
10.4.4.3. Financial Overview
10.4.4.4. Business Strategies and Development
10.4.5. JEOL
10.4.5.1. Company Overview
10.4.5.2. Product Portfolio
10.4.5.3. Financial Overview
10.4.5.4. Business Strategies and Development
10.4.6. Motion X Corporation
10.4.6.1. Company Overview
10.4.6.2. Product Portfolio
10.4.6.3. Financial Overview
10.4.6.4. Business Strategies and Development
10.4.7. TESCAN ORSAY HOLDING
10.4.7.1. Company Overview
10.4.7.2. Product Portfolio
10.4.7.3. Financial Overview
10.4.7.4. Business Strategies and Development
10.4.8. ZEISS International
10.4.8.1. Company Overview
10.4.8.2. Product Portfolio
10.4.8.3. Financial Overview
10.4.8.4. Business Strategies and Development
10.4.9. Asahi Kasei Microdevices Corporation
10.4.9.1. Company Overview
10.4.9.2. Product Portfolio
10.4.9.3. Financial Overview
10.4.9.4. Business Strategies and Development
10.4.10. TESTiLABS
10.4.10.1. Company Overview
10.4.10.2. Product Portfolio
10.4.10.3. Financial Overview
10.4.10.4. Business Strategies and Development
11. Appendix
11.1. Research Methodology
11.2. Report Assumptions
11.3. Acronyms and Abbreviations

Companies Mentioned

  • Pfizer Inc.
  • Merck KGaA
  • Merck & Co.
  • AstraZeneca PLC
  • Roche Holding AG (Genentech)
  • Astellas Pharma Inc.
  • J&J (Janssen Biotech)
  • Cipla Inc.
  • Amneal Pharma
  • Bristol Myers Squibb Co.
  • Dr. Reddy’s Laboratories, Inc.
  • Gilead Sciences Inc.
  • Endo Pharma

Methodology

Loading
LOADING...

Related Topics

Related Reports

Non-muscle Invasive Bladder Cancer Therapeutics Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa) - Product Image

Non-muscle Invasive Bladder Cancer Therapeutics Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

  • Report
  • 345 Pages
  • Global
Non-Muscle Invasive Bladder Cancer (NMIBC) Market Insight, Epidemiology and Market Forecast - 2034 - Product Image

Non-Muscle Invasive Bladder Cancer (NMIBC) Market Insight, Epidemiology and Market Forecast - 2034

  • Report
  • 265 Pages
  • Global
From
Liposomal Doxorubicin Market by Product, by Application. by End-User, and By Region - Product Image

Liposomal Doxorubicin Market by Product, by Application. by End-User, and By Region

  • Report
  • 200 Pages
  • Global
From
Liposomal Doxorubicin Market Report by Product, Application, and Region 2024-2032 - Product Image

Liposomal Doxorubicin Market Report by Product, Application, and Region 2024-2032

  • Report
  • 136 Pages
  • Global
From
Doxorubicin Market Report by Application (Breast Cancer, Ovarian Cancer, Multiple Myeloma, Kaposi Sarcoma, Leukemia, Bone Sarcoma, Endometrial Cancer, and Others), Distribution Channel (Hospital and Retail Pharmacies, Online Stores, and Others), and Region 2024-2032 - Product Image

Doxorubicin Market Report by Application (Breast Cancer, Ovarian Cancer, Multiple Myeloma, Kaposi Sarcoma, Leukemia, Bone Sarcoma, Endometrial Cancer, and Others), Distribution Channel (Hospital and Retail Pharmacies, Online Stores, and Others), and Region 2024-2032

  • Report
  • 144 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.